PharmaMar clinical trials

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company

The registry lists 67 studies whose lead sponsor is PharmaMar or one of 3 companies grouped under it. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.

Keep track of what changes. Save the PharmaMar studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed: 51
Terminated: 10
Recruiting: 4
Active, not recruiting: 1
Not yet recruiting: 1

Phase

Phase 1: 33
Phase 2: 28
Phase 3: 9

Where

Spain: 44
United States: 37
France: 17
Germany: 16
Italy: 14
United Kingdom: 11

Focus areas

Conditions PharmaMar leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Neoplasms12

Studies

Recruiting first, then most recently updated. Showing 50 of 67. Browse all 67 →

Status

Phase

Where

Registry sponsor names on this page

Focus areas

Studies